Takeda Pharmaceutical Co Ltd (OTC Pink - Current Information:TKPHF)

41.23
Delayed Data
As of Mar 14
 0.00 / 0.00%
Today’s Change
31.22
Today|||52-Week Range
52.93
+23.48%
Year-to-Date
Takeda's Entyvio Tops AbbVie's Humira in Patients With Ulcerative Colitis
Mar 12 / GuruFocus News - Paid Partner Content
Company News For Mar 5, 2019
Mar 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close41.23
Today’s open41.43
Day’s range41.23 - 41.43
Volume22,584
Average volume (3 months)191,968
Market cap$64.5B
Data as of 3:51pm ET, 03/14/2019

Growth & Valuation

Earnings growth (last year)+10.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-0.13%
P/E ratio36.1
Price/Sales2.40
Price/Book1.72

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$16.0B
Annual profit (last year)$1.7B
Net profit margin10.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, CEO &
Representative Director
Christophe Weber
Chief Financial Officer
Costa Saroukos
Corporate headquarters
Osaka, Osaka

Forecasts

Chart unavailable